Stock listing

SMMT Stock Price, News, Filings & Events — Summit Therapeutics Inc.

Selected listing: SMMT · BIVA · MXN · MX

This page tracks Summit Therapeutics Inc.'s SMMT:BIVA listing on BIVA in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SMMT:BIVA. SMMT:BIVA is the stock-level entry point for investors researching Summit Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Summit Therapeutics Inc. is a public company traded under the ticker SMMT in the American market. With a market capitalization of approximately $10.6 billion, the company focuses on developing innovative therapeutics for various medical conditions. Summit Therapeutics aims to address unmet medical needs through its advanced research and development initiatives.

SMMT:BIVAMXNMXUpdated August 21, 2026
Summit Therapeutics Inc. logo
Ticker
SMMT:BIVA
Asset type
Stock
Market cap
$10.50B
Sector
Health Technology
Industry
Biotechnology
Exchange
BIVA
Currency
MXN

Summit Therapeutics Inc. SMMT:BIVA stock context

This page tracks Summit Therapeutics Inc.'s SMMT:BIVA listing on BIVA in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SMMT:BIVA. SMMT:BIVA is the stock-level entry point for investors researching Summit Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Summit Therapeutics Inc. is a public company traded under the ticker SMMT in the American market. With a market capitalization of approximately $10.6 billion, the company focuses on developing innovative therapeutics for various medical conditions. Summit Therapeutics aims to address unmet medical needs through its advanced research and development initiatives.

Latest news from Summit Therapeutics Inc.

All Summit Therapeutics Inc. news →

Research Summit Therapeutics Inc.

Alternate listings